Two ways to invest with us
A performance-based Profit-Share program — we trade a discretionary/systematic futures strategy and share the actual results with participants, run in the open with regular statements — or a Fixed-Income program paying a defined monthly rate set out in your signed agreement. Applicants choose which fits them when they apply.
Profit-Share: performance-based, not fixed
Your return is a share of actual trading profit for the period. If the strategy loses money, your account reflects that loss — but an automatic lockout caps your maximum loss at 20% of starting capital, at which point trading halts pending review. There is no guaranteed or fixed payout. (Our Fixed-Income program works differently — see below.)
Regular statements
Every period, we post starting balance, P/L, and ending balance for every account — visible to you on your dashboard, and in aggregate on our public performance page.
Application, not checkout
We don't take money through this website. Applying starts a review and verification process; funding only happens after you've signed program documents with us directly.
12 reporting periods posted
Average return per period: +0.49% · 9 positive / 1 negative periods
View full performance historyPrefer a fixed monthly rate instead?
Our Fixed-Income program pays a fixed monthly rate — set out in your signed agreement — paid to your bank account, independent of trading results. It's a different risk/return trade-off from the profit-share program above: a defined contractual rate instead of a variable share of trading profit. Applicants choose which program fits them when they apply.
Here's some of our fixed-income performance: our current fixed-income clients are being paid monthly rates of 7.5%–10%, exactly as set out in their individual signed agreements. Rates for new applicants are set individually and may differ.
Compare both programsImportant: this is a summary. Read the full Risk Disclosure before applying — trading futures involves substantial risk, including loss of principal.